N/A
Completed N=5,094
Second Survey of Intensive Care in India
Source: ClinicalTrials.gov NCT03631927 ↗Enrolled (actual)
5,094
Serious AEs
0.0%
Results posted
Nov 2021
Primary outcomePrimary: ICU Mortality — 1092 Participants
Summary
INDICAPS was the first large scale, multicentre survey launched by the ISCCM. The aim was to gather information about ICUs, organizational characteristics, patient casemix, the types and severity of illness, monitoring and therapeutic modalities used, types of infections, and other such data. This was performed between July 2010 and April 2011 and published in 2016.[1] Over the last 8 years, there has been a significant difference in the delivery of intensive care services, critical care education, socioeconomic indicators, antibiotic resistance patterns and other aspects of practices in Indian ICUs. It is therefore necessary to revisit and resurvey the current trends in intensive care practices in India, and to reflect the vast spectrum of critical care illness, services and practices.
Similar to INDICAPS, which was a point-prevalence study of all patients present in the ICU on four different days over a one-year period, INDICAPS II will record data of all patients admitted to the ICU on 4 different days.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY ICU Mortality |
1092 | — |
| SECONDARY Hospital Mortality |
1164 | — |
| SECONDARY ICU Length of Stay |
6 | — |
| SECONDARY Hospital Length of Stay |
12 | — |
Eligibility Criteria
Inclusion Criteria
- All patients present in the ICU on August 23, 2018; October 25, 2018; December 13, 2018; April 11, 2019
Exclusion Criteria
- None
Data sourced from ClinicalTrials.gov (NCT03631927). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.